Showing results 4 to 9 of 9
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
2013 | 93 | |||
2021 | ||||
2013 | 125 | |||
Phase 3 study of first-line crizotinib vs pemetrexed−cisplatin/carboplatin in East Asian patients with ALK+ advanced non-squamous non-small cell lung cancer (NSCLC) Proceeding/Conference:Journal of Clinical Oncology | 2016 | |||
A randomized placebo-controlled phase III study of intercalated erlotinib with gemcitabine/platinum in first-line advanced non-small cell lung cancer (NSCLC): FASTACT-II Proceeding/Conference:Journal of Clinical Oncology | 2012 | 164 | ||
2018 | 60 |